Press

Current press information on migraine and headache research, migraine and headache diagnostics, migraine and headache therapy

February 28, 2020 February 28, 2020

Migraine m/f/d

Generations of students have struggled with the problem that a word can have a different gender in different languages. The assignment to female, male or objective gender often seems rather arbitrary. A typical [...]

April 7, 2019 April 7, 2019

Special print on the migraine app study 2019

Kiel, April 7, 2019. The first scientific analysis of the therapeutic behavior of migraine and headache patients when receiving digital therapy support with the migraine app was published today in the current print edition of the scientific journal Der Pain. It is about [...]

October 26, 2018 October 26, 2018

Prevent migraine attacks with immunotherapy

The diseases headache and migraine not only affect the lives of those affected, but also cause economic damage. Newly developed antibodies intervene specifically in the molecular development process of migraines and can therefore preventively reduce the likelihood [...]

September 3, 2018 September 3, 2018

Migraine Awareness Week 2018 – Migraine Awareness Week 2018

The first week of September is used internationally to educate people about migraines in order to raise awareness of the great importance of the health problem. Prejudices and stigmas should be reduced. Prof. Hartmut Göbel answers current questions about migraines, their effects [...]

July 30, 2018 July 30, 2018

EU Commission approves approval for erenumab (Aimovig)

July 30, 2018. The migraine immunotherapy with the active ingredient erenumab (Aimovig) can now also be sold in the EU. The US approval was initially given in May 2018, followed by approval in Switzerland in July. Now the [...]

April 17, 2018 April 17, 2018

Doc Esser: Dr. Heinz-Wilhelm Esser meets headache patients

Headaches are a common problem. 54 million people in Germany are affected. Dr. Heinz-Wilhelm Esser meets headache patients. During his visit to the Kiel Pain Clinic, he found out about, among other things, the causes of migraines and headaches, [...]

December 16, 2017 December 16, 2017

Immunotherapy with CGRP antibodies reduces number of headache days

On November 29, 2017, the results of two studies on the effectiveness of antibodies against CGRP in preventing chronic and episodic migraines were published in the New England Journal of Medicine1,2. The antibody therapy targets a molecule [...]

March 12, 2017 March 12, 2017

Our new clinic brochure

Dear reader, The new clinic brochure from the Kiel Pain Clinic has been updated and expanded. It is available for you to download here. The brochure has been supplemented with important innovations, such as information on the treatment process and [...]

October 1, 2016 October 1, 2016

The new migraine app – the service page

The migraine app documents the course of migraines and headaches with active data entry. It reports back aggregated information from the data set and thus supports patients and the attending physicians in monitoring progress and success as well as adjusting therapy. The migraine app contains extensive reporting, information and self-help tools.